Dear Visitor
Banyan Biomarkers has been acquired by bioMérieux, a global company specializing in in vitro diagnostics and infectious diseases.
For more information about Banyan Biomarkers please refer to the contact page or contact bioMérieux directly.

Our Mission

"Pioneer the innovation, development, and commercialization of biomarkers to accurately
and quickly diagnose traumatic brain injuries."

Evidence Based

Manage patients with a test based on data and not subjective interpretation

Improve Patient Outcomes

Identify and triage patients that need additional medical assistance


Reduce radiation exposure from unnecessary CT scans